Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Imperiale

Showing results (1-10 of 184) with videos related to

Pageof 19
Sort By:
Digestive Diseases (Basel, Switzerland)|December 5, 2012
Noninvasive screening tests for colorectal cancerThomas F Imperiale
Annals of Internal Medicine|September 1, 2025
In MASH with moderate or advanced liver fibrosis, weekly semaglutide improved histologic steatohepatitis and fibrosis at 72 wkThomas F Imperiale,
Hepatology (Baltimore, Md.)|July 1, 1999
Meta-analysis: when and howT F Imperiale
Annals of Internal Medicine|January 1, 2024
CRC screening with sigmoidoscopy extends life by 110 d; other cancer screening tests do not extend lifeThomas F Imperiale
The American Journal of Gastroenterology|September 7, 2010
Continue or discontinue warfarin for fecal occult blood testing in 2010? Does the published evidence provide an answer?Thomas F Imperiale
The American Journal of Gastroenterology|October 25, 2018
Thinking Big About Small Adenomas: Moving Toward "Precision Surveillance"Thomas F Imperiale
Annals of Internal Medicine|July 5, 2021
Colorectal cancer screening offering colonoscopy and FIT vs. colonoscopy alone improved participationThomas F Imperiale
Annals of Internal Medicine|November 3, 2025
In adults aged 45 to 49 y, active screening choices via patient portal reduced screening rates vs. mailed FIT at 6 moThomas F Imperiale,
JAMA|June 8, 1994
A meta-analysis of methods to prevent venous thromboembolism following total hip replacementT F Imperiale, T Speroff
Annals of Internal Medicine|December 31, 1997
Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysisT F Imperiale, S Birgisson
Pageof 19

Showing results (1-10 of 184) with videos related to

Sort By:
Pageof 19
Digestive Diseases (Basel, Switzerland)|December 5, 2012
Noninvasive screening tests for colorectal cancerThomas F Imperiale
Annals of Internal Medicine|September 1, 2025
In MASH with moderate or advanced liver fibrosis, weekly semaglutide improved histologic steatohepatitis and fibrosis at 72 wkThomas F Imperiale,
Hepatology (Baltimore, Md.)|July 1, 1999
Meta-analysis: when and howT F Imperiale
Annals of Internal Medicine|January 1, 2024
CRC screening with sigmoidoscopy extends life by 110 d; other cancer screening tests do not extend lifeThomas F Imperiale
The American Journal of Gastroenterology|September 7, 2010
Continue or discontinue warfarin for fecal occult blood testing in 2010? Does the published evidence provide an answer?Thomas F Imperiale
The American Journal of Gastroenterology|October 25, 2018
Thinking Big About Small Adenomas: Moving Toward "Precision Surveillance"Thomas F Imperiale
Annals of Internal Medicine|July 5, 2021
Colorectal cancer screening offering colonoscopy and FIT vs. colonoscopy alone improved participationThomas F Imperiale
Annals of Internal Medicine|November 3, 2025
In adults aged 45 to 49 y, active screening choices via patient portal reduced screening rates vs. mailed FIT at 6 moThomas F Imperiale,
JAMA|June 8, 1994
A meta-analysis of methods to prevent venous thromboembolism following total hip replacementT F Imperiale, T Speroff
Annals of Internal Medicine|December 31, 1997
Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysisT F Imperiale, S Birgisson
Pageof 19